Accéder au contenu
Merck

Anti-glioma Natural Products Downregulating Tumor Glycolytic Enzymes from Marine Actinomycete Streptomyces sp. ZZ406.

Scientific reports (2018-01-10)
Mengxuan Chen, Weiyun Chai, Tengfei Song, Mingzhu Ma, Xiao-Yuan Lian, Zhizhen Zhang
RÉSUMÉ

Marine natural products are important resources for discovering novel anticancer drugs. In this study, an extract prepared from the culture of a sea anemone-derived actinomycete Streptomyces sp. ZZ406 in soluble starch and casein-related liquid medium was found to have activity in inhibiting the proliferation of glioma cells and reducing the production of lactate in glioma cells. Chemical investigation of this active crude extract resulted in the isolation of four new compounds and seven known ones. Structures of the new compounds were determined by a combination of extensive NMR analyses, HRESIMS and MS-MS data, electronic circular dichroism calculation, chemical degradation, and Marfey's method. New compound 1 showed potent activity against the proliferation of different glioma cells with IC

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
D-Leucine, ReagentPlus®, 99%
Supelco
Nα-(2,4-dinitro-5-fluorophényl)-L-alaninamide, for chiral derivatization, LiChropur, ≥99.0%